FDA Inspection
Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. – FDA Inspection, Oct 28, 2016
Record Details
This FDA Inspection record concerns Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc., with an inspection on October 28, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 28, 2016
- Product Type
- Drugs
View Company Profile
ID · efbd4327-52cd-49bb-a74a-7776f803c06f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 998826
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | VAI | New Orleans District Office | Drug Quality Assurance |
| April 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.